PMID- 28406754 OWN - NLM STAT- MEDLINE DCOM- 20170724 LR - 20181202 IS - 1937-3392 (Electronic) IS - 1937-3384 (Print) IS - 1937-3384 (Linking) VI - 23 IP - 4 DP - 2017 Apr TI - Spheroid Coculture of Hematopoietic Stem/Progenitor Cells and Monolayer Expanded Mesenchymal Stem/Stromal Cells in Polydimethylsiloxane Microwells Modestly Improves In Vitro Hematopoietic Stem/Progenitor Cell Expansion. PG - 200-218 LID - 10.1089/ten.tec.2016.0329 [doi] AB - While two-dimensional (2D) monolayers of mesenchymal stem/stromal cells (MSCs) have been shown to enhance hematopoietic stem/progenitor cell (HSPC) expansion in vitro, expanded cells do not engraft long term in human recipients. This outcome is attributed to the failure of 2D culture to recapitulate the bone marrow (BM) niche signal milieu. Herein, we evaluated the capacity of a novel three-dimensional (3D) coculture system to support HSPC expansion in vitro. A high-throughput polydimethylsiloxane (PDMS) microwell platform was used to manufacture thousands of uniform 3D multicellular coculture spheroids. Relative gene expression in 3D spheroid versus 2D adherent BM-derived MSC cultures was characterized and compared with literature reports. We evaluated coculture spheroids, each containing 25-400 MSCs and 10 umbilical cord blood (CB)-derived CD34(+) progenitor cells. At low exogenous cytokine concentrations, 2D and 3D MSC coculture modestly improved overall hematopoietic cell and CD34(+) cell expansion outcomes. By contrast, a substantial increase in CD34(+)CD38(-) cell yield was observed in PDMS microwell cultures, regardless of the presence or absence of MSCs. This outcome indicated that CD34(+)CD38(-) cell culture yield could be increased using the microwell platform alone, even without MSC coculture support. We found that the increase in CD34(+)CD38(-) cell yield observed in PDMS microwell cultures did not translate to enhanced engraftment in NOD/SCID gamma (NSG) mice or a modification in the relative human hematopoietic lineages established in engrafted mice. In summary, there was no statistical difference in CD34(+) cell yield from 2D or 3D cocultures, and MSC coculture support provided only modest benefit in either geometry. While the high-throughput 3D microwell platform may provide a useful model system for studying cells in coculture, further optimization will be required to generate HSPC yields suitable for use in clinical applications. FAU - Futrega, Kathryn AU - Futrega K AD - 1 Stem Cell Therapies Laboratory, Translational Research Institute, Queensland University of Technology , Brisbane, Australia . FAU - Atkinson, Kerry AU - Atkinson K AD - 1 Stem Cell Therapies Laboratory, Translational Research Institute, Queensland University of Technology , Brisbane, Australia . FAU - Lott, William B AU - Lott WB AD - 1 Stem Cell Therapies Laboratory, Translational Research Institute, Queensland University of Technology , Brisbane, Australia . FAU - Doran, Michael R AU - Doran MR AD - 1 Stem Cell Therapies Laboratory, Translational Research Institute, Queensland University of Technology , Brisbane, Australia . AD - 2 Mater Research Institute - University of Queensland, Translational Research Institute , Brisbane, Australia . LA - eng PT - Journal Article PL - United States TA - Tissue Eng Part C Methods JT - Tissue engineering. Part C, Methods JID - 101466663 RN - 0 (Dimethylpolysiloxanes) RN - 63148-62-9 (baysilon) SB - IM MH - Animals MH - *Cell Proliferation MH - Coculture Techniques/methods MH - Dimethylpolysiloxanes/*chemistry MH - Graft Survival MH - Hematopoietic Stem Cell Transplantation MH - Hematopoietic Stem Cells/cytology/*metabolism MH - Heterografts MH - Humans MH - Mesenchymal Stem Cells/cytology/*metabolism MH - Mice, Inbred NOD MH - Mice, SCID MH - Spheroids, Cellular/cytology/*metabolism PMC - PMC5397247 OTO - NOTNLM OT - co-culture OT - cord blood hematopoietic stem cells OT - engraftment OT - mesenchymal stem cells OT - microwell OT - spheroid culture COIS- No competing financial interests exist. EDAT- 2017/04/14 06:00 MHDA- 2017/07/25 06:00 PMCR- 2017/04/01 CRDT- 2017/04/14 06:00 PHST- 2017/04/14 06:00 [entrez] PHST- 2017/04/14 06:00 [pubmed] PHST- 2017/07/25 06:00 [medline] PHST- 2017/04/01 00:00 [pmc-release] AID - 10.1089/ten.tec.2016.0329 [pii] AID - 10.1089/ten.tec.2016.0329 [doi] PST - ppublish SO - Tissue Eng Part C Methods. 2017 Apr;23(4):200-218. doi: 10.1089/ten.tec.2016.0329.